Skip to content

Study of effect of blood pressure suppression by intake of Mekabu

Study of effect of blood pressure suppression by intake of Mekabu - Study of effect of blood pressure suppression by intake of Mekabu

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000046597
Enrollment
60
Registered
2022-01-11
Start date
2022-01-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Intake of mekabu daily for 4 weeks. none

Sponsors

Healthcare Systems Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document 2.Healthy Japanese who are 20 to 64 years old 3.Persons with systolic blood pressure less than 160 mmHg and diastolic blood pressure less than 100 mmHg 4.Persons who satisfy 3 and the top of systolic blood pressure during the pre-intake test

Exclusion criteria

Exclusion criteria: 1.Persons who have a chronic disease and is under medication, or has a serious disease history 2.Persons who are allergic to the test food 3.Persons who regularly take large amounts of the test food 4.Persons who regularly use medicines, specified insurance foods, health foods 5.Persons who have a history of hypertension treatment 6.Persons who participated in other examination during the first month before the start of the exam, or those who plan to participate in other exams following this exam 7.Persons who are judged inappropriate for the exam by the principal investigator 8.Persons who are pregnant, planning or hoping to be pregnant during the study period, or breastfeeding

Design outcomes

Primary

MeasureTime frame
Blood pressure (systolic blood pressure, diastolic blood pressure) at the beginning of the test or after the intake for 4 weeks.

Secondary

MeasureTime frame
Salt intake, physical examination (body height, weight, BMI) and questionnaire on swelling (VAS) at the beginning of the test or after the intake for 4 weeks.

Countries

Japan

Contacts

Public Contactmari shimura

Healthcare Systems Co., Ltd. Research and Development Department

shimura.mari@hc-sys.jp0368092722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026